CHC Healthcare Group (TPE:4164)
Taiwan · Delayed Price · Currency is TWD 30.30
-0.40 (-1.30%)
At close: Mar 27, 2026
CHC Healthcare Group Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 186.28 | 168.38 | 418.87 | 356.57 | 381.63 |
Depreciation & Amortization | 659.19 | 633.97 | 594.46 | 499.38 | 460.59 |
Other Amortization | 15.01 | 9.24 | 9.87 | 10.65 | 10.57 |
Loss (Gain) From Sale of Assets | 6.78 | -2.09 | 1.33 | -55.81 | -31.5 |
Loss (Gain) From Sale of Investments | 4.45 | -4.03 | -13.09 | 17.99 | 0.96 |
Loss (Gain) on Equity Investments | 5.28 | -1 | -1.6 | 0.33 | -8.64 |
Stock-Based Compensation | - | - | 0.29 | 1.76 | 3.21 |
Provision & Write-off of Bad Debts | 13.04 | -2.04 | 0.28 | 4.16 | 0.32 |
Other Operating Activities | 78.05 | -107.44 | 49.95 | 32.78 | 6.82 |
Change in Accounts Receivable | 11.54 | -294.76 | -126.88 | -168.1 | 79.66 |
Change in Inventory | -172.66 | -255.6 | -76.69 | -209.23 | 7.16 |
Change in Accounts Payable | 31.99 | 62.67 | 48.7 | 128.55 | 26.77 |
Change in Unearned Revenue | 225.7 | 148.09 | 48.65 | 8.19 | -115.24 |
Change in Other Net Operating Assets | -60.6 | -278.49 | 24.94 | -1.28 | -144.25 |
Operating Cash Flow | 1,002 | 99.37 | 962.59 | 656.66 | 692.8 |
Operating Cash Flow Growth | 908.84% | -89.68% | 46.59% | -5.22% | -24.37% |
Capital Expenditures | -868.13 | -431.09 | -549.67 | -682.63 | -514.09 |
Sale of Property, Plant & Equipment | 14.27 | 11.05 | 1.07 | 1.24 | - |
Cash Acquisitions | - | -39.25 | -49.52 | - | -315.03 |
Divestitures | - | 75 | - | - | - |
Sale (Purchase) of Intangibles | -5.2 | - | -26 | - | - |
Sale (Purchase) of Real Estate | -24 | -44.71 | -29.39 | 163.94 | 51.97 |
Investment in Securities | -103.96 | -17.59 | 143.65 | 133.1 | -74.12 |
Other Investing Activities | -653.86 | -98.27 | 9.4 | 44.38 | -139.09 |
Investing Cash Flow | -1,641 | -544.86 | -500.47 | -339.98 | -990.35 |
Short-Term Debt Issued | 5,400 | 2,850 | 2,104 | 3,481 | 3,418 |
Long-Term Debt Issued | 2,027 | 197.62 | 515.94 | 2,635 | 611.19 |
Total Debt Issued | 7,427 | 3,047 | 2,620 | 6,116 | 4,029 |
Short-Term Debt Repaid | -5,167 | -2,352 | -2,058 | -3,778 | -2,972 |
Long-Term Debt Repaid | -1,248 | -252.73 | -305.36 | -2,372 | -448.09 |
Total Debt Repaid | -6,415 | -2,605 | -2,363 | -6,150 | -3,420 |
Net Debt Issued (Repaid) | 1,012 | 442.32 | 256.93 | -33.7 | 609.07 |
Issuance of Common Stock | 0.56 | 0.78 | 18.37 | 14.36 | 174.48 |
Common Dividends Paid | -251.97 | -334.5 | -324.72 | -323.88 | -313.65 |
Other Financing Activities | 23.32 | 79.64 | 7.37 | -3.23 | -54.84 |
Financing Cash Flow | 784.13 | 188.24 | -42.05 | -346.45 | 415.06 |
Foreign Exchange Rate Adjustments | -1 | 7.65 | -1.54 | 8.69 | -4.09 |
Net Cash Flow | 144.71 | -249.6 | 418.53 | -21.08 | 113.41 |
Free Cash Flow | 134.33 | -331.72 | 412.92 | -25.97 | 178.7 |
Free Cash Flow Growth | - | - | - | - | -8.25% |
Free Cash Flow Margin | 3.05% | -9.21% | 10.65% | -0.87% | 7.32% |
Free Cash Flow Per Share | 0.69 | -1.70 | 2.13 | -0.14 | 0.96 |
Cash Interest Paid | 105.89 | 96.07 | 86.23 | 53.88 | 47.46 |
Cash Income Tax Paid | 72.04 | 190.56 | 107.89 | 110.82 | 110.35 |
Levered Free Cash Flow | -132.19 | -338.76 | 401.21 | -72.8 | 58.2 |
Unlevered Free Cash Flow | -78.28 | -293.26 | 439.67 | -46.64 | 78.99 |
Change in Working Capital | 34.4 | -595.62 | -97.77 | -211.16 | -131.16 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.